BioNTech will attempt shot for malaria next

27th July 2021

By: Bloomberg

  

Font size: - +

BioNTech will seek to follow its successful Covid-19 vaccine with a shot to prevent malaria, both its first solo project and first new infectious-disease effort since the pandemic began.

The German biotech aims to start patient trials of a malaria shot by the end of next year. Backed by the World Health Organization, European Commission and the kENUP Foundation, the project will simultaneously seek to build out the infrastructure necessary to produce any successful malaria shot, as well as other messenger RNA vaccines, in Africa, BioNTech CEO Ugur Sahin said.

“This is really about our goal to bring our vaccine to people who need it,” Sahin said in an interview. “We have the technology. We believe that we can help.”

Malaria kills some 400 000 people a year -- most of them young children in Africa -- and has been a notoriously tricky target for vaccine makers. After decades of work, the first shot to clear the WHO’s 75% target for efficacy came this year. Developed by scientists at the University of Oxford, it prevented 77% of cases in a 450-child study in Burkina Faso. A 4 800-child trial is planned to confirm the results.

Like the Covid vaccine BioNTech developed with Pfizer Inc., the malaria shot will use messenger RNA technology, making it possible to shorten the amount of time it takes to develop the shot. BioNTech plans to evaluate as many as 20 vaccine candidates and bring the most effective ones into clinical testing, Sahin said.

Edited by Bloomberg

Comments

The functionality you are trying to access is only available to subscribers.

If you are already a subscriber, you can Login Here.

If you are not a subscriber, you can subscribe now, by selecting one of the below options.

For more information or assistance, please contact us at subscriptions@creamermedia.co.za.

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION